ArriVent BioPharma, Inc.

Q1 2024 13F Holders

Symbol
AVBP
CUSIP
04272N102
Type
Equity
Class
COM
Num filings
57
Total reported value, excl. options
$390 M
Manager Report Date Value ($000) Shares Option Type